基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 171.02
成立日期: 05/02/2001
 
分析
市值分佈:
87.19%
大市值
8.91%
中市值
3.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 251  
0%
 
100%
     10大 (49.74%)
代號 名稱 佔比% 持有日期
APLSApellis Pharmaceuticals0.1828/02/2026
ALMSAlumis Inc.0.1828/02/2026
RAREUltragenyx Pharmaceutical0.1828/02/2026
DICE--0.1731/07/2023
BCRXBioCryst Pharmaceuticals0.1728/02/2026
VERAVera Therapeutics0.1728/02/2026
CNTACentessa Pharmaceuticals plc0.1628/02/2026
WVEWave Life Sciences Ltd0.1628/02/2026
DYNDyne Therapeutics0.1628/02/2026
SNDXSyndax Pharmaceuticals0.1528/02/2026
GRALGRAIL Inc.0.1528/02/2026
IRONDisc Medicine0.1528/02/2026
VCELVericel Corp0.1528/02/2026
SMMTSummit Therapeutics0.1428/02/2026
ZYMEZymeworks0.1428/02/2026
AUPHAurinia Pharmaceuticals0.1428/02/2026
STOKStoke Therapeutics0.1428/02/2026
GRFSGrifols SA0.1428/02/2026
DFTXDefinium Therapeutics Inc0.1428/02/2026
AGIOAgios Pharmaceuticals0.1428/02/2026
  1    2    3    4   5    6    7    8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.